LAMEA Neurovascular Devices Market

LAMEA Neurovascular Devices Market Size, Share & Industry Trends Analysis Report By End User (Hospital & Surgery Centers, Ambulatory Care Centers and Research laboratories & Academic Institutes), By Technology, By Disease Pathology, By Country and Growth Forecast, 2022 - 2028

Report Id: KBV-14764 Publication Date: March-2023 Number of Pages: 136
Special Offering:
Industry Insights | Market Trends
Highest number of Tables | 24/7 Analyst Support

Market Report Description

The Latin America, Middle East and Africa Neurovascular Devices Market would witness market growth of 12.3% CAGR during the forecast period (2022-2028).

Clinical specialists and neurosurgeons are increasingly examining therapeutic options that can significantly lower the risk of patient fatality or catastrophic neurovascular illnesses. In addition, the demand for potent neurovascular therapeutics is steadily expanding due to the growing population of patients suffering from neurovascular diseases and the increasing severity of the diseases in the target population.

When a blood clot restricts blood flow to the brain, starving it of oxygen and blood, clot removal items called neuro thrombectomy devices are utilized to treat ischemic stroke. Mechanical thrombectomy, where a specialist mechanically removes a clot via clot retrievers or suction equipment, is the first-line treatment for ischemic stroke. This procedure also includes thrombolytic therapy, wherein medication is given to dissolve the clot.

In Israel, stroke is third on the list of leading causes of death. In 2013, 5.6% of all deaths in Israel resulted from a stroke. In addition to mortality, the most significant consequence of a stroke is long-term impairment, particularly among the elderly. Around 15,000 strokes occur each year in Israel, according to national survey figures. Ischemic strokes, caused by blockage of cerebral blood arteries, account for approximately 85% of all strokes. In addition, 15% are hemorrhagic strokes caused by a ruptured blood artery that bleeds into the brain tissue. The primary risk factor for stroke is high blood pressure, which is particularly prevalent in the older population. The growing incidence of strokes and R&D efforts are predicted to support the regional market’s growth.

The Brazil market dominated the LAMEA Neurovascular Devices Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $93.1 million by 2028. The Argentina market is experiencing a CAGR of 12.9% during (2022 - 2028). Additionally, The UAE market would display a CAGR of 12% during (2022 - 2028).

Based on End User, the market is segmented into Hospital & Surgery Centers, Ambulatory Care Centers and Research laboratories & Academic Institutes. Based on Technology, the market is segmented into Embolization & Coiling (Embolic Coils, Flow Diversion Devices and Liquid Embolic Agents), Neurothrombectomy Devices (Clot Retrievers, Suction & Aspiration Devices, and Snares), Cerebral Balloon Angioplasty & Stenting Systems (Carotid Artery Stents and Embolic Protection Systems), and Support Devices (Microcatheters and Microguidewires). Based on Disease Pathology, the market is segmented into Cerebral Aneuryms, Ischemic Strokes, Cartoid Artery Stenosis, Arteriovenous Malformation & Fistulas (AVM) and Others. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.

Free Valuable Insights: The Worldwide Neurovascular Devices Market is Projected to reach USD 4.2 Billion by 2028, at a CAGR of 8.8%

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Abbott Laboratories, Medtronic PLC, Stryker Corporation, Johnson & Johnson, Terumo Corporation, Merit Medical Systems, Inc., MicroPort Scientific Corporation, Medikit Co. Ltd., and W. L. Gore & Associates, Inc.

Scope of the Study

Market Segments Covered in the Report:

By End User

  • Hospital & Surgery Centers
  • Ambulatory Care Centers
  • Research laboratories & Academic Institutes

By Technology

  • Embolization & Coiling
    • Embolic Coils
    • Flow Diversion Devices
    • Liquid Embolic Agents
  • Neurothrombectomy Devices
    • Clot Retrievers
    • Suction & Aspiration Devices
    • Snares
  • Cerebral Balloon Angioplasty & Stenting Systems
    • Carotid Artery Stents
    • Embolic Protection Systems
  • Support Devices
    • Microcatheters
    • Microguidewires

By Disease Pathology

  • Cerebral Aneuryms
  • Ischemic Strokes
  • Cartoid Artery Stenosis
  • Arteriovenous Malformation & Fistulas (AVM)
  • Others

By Country

  • Brazil
  • Argentina
  • UAE
  • Saudi Arabia
  • South Africa
  • Nigeria
  • Rest of LAMEA

Key Market Players

List of Companies Profiled in the Report:

  • Abbott Laboratories
  • Medtronic PLC
  • Stryker Corporation
  • Johnson & Johnson
  • Terumo Corporation
  • Merit Medical Systems, Inc.
  • MicroPort Scientific Corporation
  • Medikit Co. Ltd.
  • W. L. Gore & Associates, Inc.
Need a report that reflects how COVID-19 has impacted this market and its growth? Download Free Sample Now


Call: +1(646) 600-5072


  • Buy Sections of This Report
  • Buy Country Level Reports
  • Request for Historical Data
  • Discounts Available for Start-Ups & Universities

Unique Offerings Unique Offerings

  • Exhaustive coverage
  • The highest number of Market tables and figures
  • Subscription-based model available
  • Guaranteed best price
  • Support with 10% customization free after sale

Trusted by over
5000+ clients

Our team of dedicated experts can provide you with attractive expansion opportunities for your business.

Client Logo